251 (Pramipexole Dihydrochloride Extended-Release 0.375 mg)
Pill with imprint 251 is White, Round and has been identified as Pramipexole Dihydrochloride Extended-Release 0.375 mg. It is supplied by Par Pharmaceutical Inc.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.375 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 251
Pramipexole Dihydrochloride Extended-Release
- Imprint
- 251
- Strength
- 0.375 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Inc
- National Drug Code (NDC)
- 10370-0251
- Inactive Ingredients
-
hypromelloses,
corn starch,
silicon dioxide,
D&C Yellow No. 10,
hydrogenated cottonseed oil,
hydroxypropyl cellulose,
magnesium stearate,
mannitol,
microcrystalline cellulose,
titanium dioxide,
magnesium silicate,
soya lecithin,
xanthan gum
Note: Inactive ingredients may vary.
Related images for "251"
More about pramipexole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (216)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Pramipexole (Advanced Reading)
- Pramipexole Extended-Release Tablets
- Pramipexole Tablets
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.